Kimi Iguchi
Director of Finance/CFO en SAGE THERAPEUTICS, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
En la actualidad, Kimi E. Iguchi ocupa el cargo de directora financiera y tesorera de SAGE Therapeutics, Inc. La Sra. Iguchi también forma parte del consejo de administración de Disarm Therapeutics, Inc. Anteriormente fue Vicepresidenta de Finanzas de Cyberkinetics Neurotechnology Systems, Inc., Directora de Operaciones para la región de América del Norte en Santhera Pharmaceuticals Holding AG, Directora de Informes Externos en Biogen, Inc. y Directora de Finanzas en Biogen MA, Inc. (una filial de Biogen, Inc.), Directora Senior de Finanzas, Informes y Análisis en Millennium Pharmaceuticals, Inc. y Gerente de Aseguramiento de Negocios en PricewaterhouseCoopers LLP. La Sra. Iguchi se licenció en la Universidad Drew y obtuvo un MBA en la Universidad Northeastern.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0.14% | 13/02/2024 | 81 679 ( 0.14% ) | 2 M $ | 31/03/2024 |
Cargos activos de Kimi Iguchi
| Empresas | Cargo | Inicio |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2013 |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Director/Board Member | 25/10/2018 |
Antiguos cargos conocidos de Kimi Iguchi.
| Empresas | Cargo | Fin |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01/09/2011 |
Cyberkinetics Neurotechnology Systems, Inc.
 Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Director of Finance/CFO | 31/05/2007 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/1998 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/1995 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Formación de Kimi Iguchi.
| Drew University | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| Empresas privadas | 5 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kimi Iguchi
